Inquiry Basket
Loading ......
Filter By Product Search for
LFNG
LFNG Full Name
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
LFNG Introduction
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (LFNG), commonly known as Lunatic Fringe, is a Golgi-resident glycosyltransferase that catalyzes the addition of N-acetylglucosamine (GlcNAc) to O-fucose residues on the extracellular domain of Notch receptors. Encoded by the LFNG gene on chromosome 7p22.3, LFNG is one of three mammalian Fringe proteins (along with Manic Fringe/MFNG and Radical Fringe/RFNG) that differentially modify Notch receptors to regulate their ligand-binding specificities. This glycosylation event is a critical post-translational modification that modulates the responsiveness of Notch receptors to Delta-like (DLL) versus Jagged (JAG) family ligands, thereby shaping cell fate decisions during development and adult tissue homeostasis.
Figure 1. Strcuture of LFNG.
Notch Receptor Glycosylation and Signal Modulation
LFNG functions within the secretory pathway, where it specifically extends O-fucose monosaccharides attached to consensus sequences within the epidermal growth factor (EGF)-like repeats of the Notch extracellular domain. The GlcNAc added by LFNG can be further elongated by galactosyltransferases and sialyltransferases to produce complex tetrasaccharide structures. The presence of LFNG-modified O-fucose glycans on specific EGF repeats of Notch receptors — particularly EGF repeats 8 and 12 — enhances the binding affinity for Delta-like ligands (DLL1, DLL4) while simultaneously inhibiting Notch activation by Jagged ligands (JAG1, JAG2). This ligand-bias mechanism enables Fringe proteins to establish signaling boundaries in developing tissues where different cell populations express different ligand repertoires. LFNG is itself subject to transcriptional regulation by Notch signaling, creating a feedback loop that reinforces and sharpens boundaries of Notch activity. The periodic expression of LFNG during vertebrate somitogenesis — oscillating in synchrony with the segmentation clock genes — is essential for the proper spacing and formation of somites, the embryonic precursors of the vertebral column and skeletal muscle.
LFNG in Skeletal Development, Spondylocostal Dysostosis, and Tissue Homeostasis
Homozygous or compound heterozygous loss-of-function mutations in LFNG cause a severe form of autosomal recessive spondylocostal dysostosis (SCD), a congenital disorder characterized by malformations of the vertebral column and ribs resulting from defective somitogenesis. Affected individuals display multiple vertebral segmentation defects (hemivertebrae, block vertebrae, butterfly vertebrae), rib fusions and malformations, and truncal shortening with preserved limb length. SCD caused by LFNG mutations is among a family of related disorders caused by mutations in other Notch pathway components including DLL3, MESP2, and HES7, all of which disrupt the segmentation clock that governs somite boundary formation. LFNG also plays important roles in the maintenance of adult tissues: in the intestinal epithelium, LFNG-mediated Notch glycosylation influences the balance between secretory and absorptive cell differentiation; in the hematopoietic system, LFNG modulates T cell versus B cell lineage commitment; and in the mammary gland, LFNG participates in regulating stem cell self-renewal and lineage specification. Dysregulation of LFNG expression has been reported in certain cancers, including breast cancer and T-cell acute lymphoblastic leukemia (T-ALL), where altered Notch ligand specificity may contribute to aberrant Notch activation.
Alternate Names for LFNG
LFNG; LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase; SCDO3; beta-1,3-N-acetylglucosaminyltransferase lunatic fringe;
Loading ......
